United States Neuroscience Market 2033 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

The Global Neuroscience Market reached US$ 44.6 billion in 2024 and is expected to reach US$ 73.5 billion by 2033, growing at a CAGR of 5.7% during the forecast period 2025-2033, according to DataM Intelligence report.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/neuroscience-market?sb

Key Development:

United States: Recent Neuroscience Developments

✅ In January 2026, Aspen Neuroscience completed dosing of the third cohort in its Phase 1/2a ASPIRO clinical trial for a personalized autologous cell therapy targeting Parkinson's disease. The milestone advances its regenerative neuroscience pipeline. It supports progress in disease-modifying therapies for neurodegenerative disorders.

✅ In November 2025, Aspen Neuroscience raised USD 115 million in Series C funding to accelerate clinical development and manufacturing scale-up of its personalized cell therapy programs for neurological diseases. The investment strengthens late-stage neuroscience R&D. It supports expansion toward broader CNS indications.

✅ In December 2025, Precision Neuroscience expanded U.S. clinical adoption of its ultra-thin cortical electrode array for high-resolution brain-computer interface research. The minimally invasive technology enhances neural signal mapping. It advances next-generation neurotechnology and neuromodulation research.

✅ In November 2025, U.S. federal neuroscience programs increased public-private research collaboration under ongoing brain-mapping and neurotechnology initiatives. The focus is on advanced neural interfaces and translational brain research. It accelerates innovation across clinical and applied neuroscience.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=neuroscience-market

Japan: Recent Neuroscience Developments

✅ In January 2026, researchers at Nagoya University successfully created functional human brain circuit models using fused stem-cell-derived organoids. The development revealed new insights into thalamocortical network formation. It advances disease modeling for neurodevelopmental and neurological disorders.

✅ In December 2025, Japan's Brain/MINDS 2.0 program reported new genetic insights related to ALS and expanded primate neuroscience research platforms. The initiative strengthens translational and precision neuroscience. It supports long-term neurological disease research.

✅ In November 2025, Japan expanded large-scale genome-wide association studies for neurodegenerative diseases under national neuroscience programs. The effort improves understanding of disease onset and progression. It reinforces Japan's leadership in neurogenetics research.

✅ In November 2025, Japan-U.S. collaborative neuroscience research programs opened new joint study initiatives focusing on brain circuits and cognition. The partnerships aim to accelerate shared neuroscience discoveries. It strengthens international cooperation in brain science.

Key Players:

=> GE HealthCare, Medtronic plc, F. Hoffmann-La Roche Ltd., Siemens Healthcare Private Limited, B. Braun Melsungen AG, Stryker Corporation, Abbott Laboratories, Boston Scientific Corporation, Terumo Corporation, Bio-Rad Laboratories, Inc. and among others.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/neuroscience-market?sb

Key Segments:

By Type

Cellular and Molecular Neuroscience - ~28% share

Dominates due to extensive use in drug discovery, neurodegenerative disease research, and molecular-level brain studies.

Cognitive Neuroscience - ~18% share

Strong adoption in brain-behavior research, mental health studies, and cognitive disorder analysis.

Clinical Neuroscience - ~20% share

Driven by increasing neurological disorder prevalence and clinical diagnostics applications.

Developmental Neuroscience - ~12% share

Growth supported by rising research on brain development disorders and pediatric neurology.

Behavioral Neuroscience - ~10% share

Used extensively in psychology, psychiatry, and behavioral disorder research.

Computational Neuroscience - ~7% share

Emerging segment driven by AI, big data, and brain modeling applications.

Others - ~5% share

By Component

Instruments - ~45% share

Includes imaging systems, microscopes, and surgical instruments; forms the backbone of neuroscience research infrastructure.

Consumables - ~35% share

Reagents, assay kits, probes, and lab supplies witness consistent demand due to recurring usage.

Software & Services - ~20% share

Growing adoption of data analytics, imaging software, and outsourced research services.

By Technology

Brain Imaging - ~30% share

Widely used in diagnostics, research, and cognitive studies; includes MRI, PET, and CT-based technologies.

Neuro-Microscopy - ~22% share

High demand for cellular-level visualization and advanced brain structure analysis.

Stereotaxic Surgeries - ~15% share

Critical for precision brain interventions and experimental neuroscience studies.

Neuro-Proteomic Analysis - ~13% share

Expanding role in biomarker discovery and neurodegenerative disease research.

Neuro-Cellular Manipulation - ~12% share

Includes optogenetics and gene-editing tools; rapidly growing research applications.

Others - ~8% share

By End-User

Hospitals - ~25% share

Adoption driven by neurological diagnostics and clinical research activities.

Specialty Clinics - ~15% share

Focused on neurological and mental health treatments.

Diagnostic Centers - ~18% share

Increasing use of advanced imaging and diagnostic technologies.

Research and Academic Institutes - ~35% share

Largest end-user segment due to extensive neuroscience research funding and academic studies.

Others - ~7% share

By Region

North America - ~35% share

Strong research funding, advanced healthcare infrastructure, and presence of leading neuroscience research institutes.

Latin America - ~8% share

Gradual growth supported by expanding academic research and healthcare investments.

Europe - ~25% share

Robust neuroscience research ecosystem and favorable government funding programs.

Asia Pacific - ~27% share

Fastest-growing region driven by rising R&D investments, expanding academic institutions, and increasing neurological disorder burden.

Middle East & Africa - ~5% share

Moderate growth supported by healthcare infrastructure development and academic collaborations.

FAQ

What is the current size of the Neuroscience Market?

A: In 2024, the Neuroscience Market was valued at US$ 44.6 billion, reflecting its strong industry presence.

Q2: How large is the Neuroscience Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Neuroscience Market will grow to around US$ 73.5 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Neuroscience Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 5.7% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.